CLINSQUARE: CLINICAL RESEARCH COURSES
Saturday, June 7, 2025
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home2020June

Monthly Archives: June, 2020

PFIZER ANNOUNCES START OF FOUR PHASE 3 CLINICAL TRIALS FOR INVESTIGATIONAL VACCINES

admin - 0
June 22, 2020: "Pfizer Inc. announced the initiation of four Phase 3 clinical trials within its current pipeline of investigational vaccines: Two studies (NCT04382326 and...

Coronil: ICMR, AYUSH Ministry distance themselves from Patanjali’s cure for coronavirus

admin - 0
June 23, 2020: "As per India Today Indian Council of Medical Research and AYUSH Ministry have distanced themselves from Patanjali's cure for coronavirus Coronil. Yoga...

Coronavirus (COVID-19) Update: Daily Roundup June 22, 2020

admin - 0
June 22, 2020: "The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA...

FDA Accepts sBLA for BOTOX® (onabotulinumtoxinA) for the Treatment of Pediatric Patients with Neurogenic Detrusor Overactivity

admin - 0
 June 22, 2020: "Allergan an AbbVie company announced that the U.S.FDA has accepted the company's supplemental biologics license application (sBLA) to expand the BOTOX® prescribing...

Cipla launches Cipremi (remdesivir lyophilised powder for injection 100 mg), the only U.S. FDA approved EUA treatment for patients with severe COVID-19 disease

admin - 0
June 21, 2020: "Cipla Limited announced the launch of remdesivir under its brand name CIPREMI. The U.S. FDA issued an Emergency Use Authorization (EUA) to...

FDA Oks Crysvita® for the Treatment of Tumor-Induced Osteomalacia (TIO)

admin - 0
 June 18, 2020: "Ultragenyx Pharmaceutical announced that the U.S. FDA has approved Crysvita® (burosumab) for the treatment of fibroblast growth factor 23 (FGF23)-related hypophosphatemia in tumor-induced...

FDA Approves Evoke’s GIMOTI™

admin - 0
June 19, 2020: Evoke Pharma announced that the U.S. FDA has approved the New Drug Application (NDA) for GIMOTI™ (metoclopramide) nasal spray, the first...

Dupixent® approved in China for adults with atopic dermatitis

admin - 0
June 19, 2020: The National Medical Products Administration (NMPA) in China has approved Dupixent® (dupilumab) for the treatment of moderate-to-severe atopic dermatitis in adults whose...

Novartis discontinues hydroxychloroquine clinical trial

admin - 0
"Novartis discontinues hydroxychloroquine clinical trial based on slow enrollment, remains committed to pandemic research efforts June 19, 2020: Novartis has made the decision to stop...

Coronavirus (COVID-19) Update: Daily Roundup June 19, 2020

admin - 0
June 19, 2020: The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA...

India approved Glenmark’s Favipiravir for the treatment of mild to moderate COVID-19

admin - 0
"Glenmark becomes the first pharmaceutical company in India to receive regulatory approval for oral antiviral Favipiravir, for the treatment of mild to moderate COVID-19 June...

Roche’s IPATential150 study met one of its co-primary endpoints

admin - 0
June 19, 2020: "Roche announced that the phase III IPATential150 study met its co-primary endpoint of radiographic progression-free survival (rPFS) in patients with metastatic...
1...345...8Page 4 of 8
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved